# Heropnames bij atriumfibrilleren dalen, sterfte blijft stabiel — populatiestudie

*geplaatst 2026-11-03 · Atriumfibrilleren · International journal of cardiology · doi 10.1016/j.ijcard.2026.134952 · https://hartvaat.nl/2026/12/15/heropnames-bij-atriumfibrilleren-dalen-sterfte-blijft-stabiel-populatiestudie/*

Een populatiestudie onder 12.141 patiënten met een eerste ziekenhuisopname voor atriumfibrilleren (2008-2021) toont aan dat de sterftecijfers na één jaar stabiel blijven op 11,3%. De algemene heropnamencijfers daalden significant (gecorrigeerd RR 0,87), met name voor AF-specifieke opnames, vooral bij patiënten jonger dan 70 jaar. Deze trend wijst op verbeterde zorgpaden of preventie, maar het uitblijven van een sterftecijferdaling benadrukt de noodzaak van gerichte strategieën om cerebrovasculaire en bloedingen te verminderen.

## English: Temporal trends of outcomes following first hospitalization due to atrial fibrillation- a population-based study.

A population-based cohort study of 12,141 patients hospitalized for first-onset atrial fibrillation (2008–2021) found that one-year all-cause mortality remained stable at 11.3%. Overall readmission rates declined significantly (adjusted RR 0.87), with AF-specific readmissions dropping most sharply in patients under 70. While these trends suggest improved acute management or prevention, the lack of mortality reduction highlights the ongoing need for targeted strategies to reduce stroke and bleeding complications.

## Abstract (original, from the publication)

BACKGROUND: Atrial fibrillation (AF) represents a substantial cause of hospitalization and healthcare burden. This study aimed to examine temporal trends in outcomes following an initial hospitalization for AF. METHODS: We analyzed electronic health records from Clalit Health Services, Israel's largest healthcare provider, from 2008 to 2021. The study included 12,141 patients with newly diagnosed AF requiring hospitalization. We examined one-year outcomes including all-cause mortality, hospitalizations, bleeding events, and cerebrovascular accidents, stratified by age and sex. RESULTS: One-year mortality rates remained stable at 11.3% over the study period (adjusted RR per year: 1.01, 95% CI: 0.99-1.02). All-cause hospitalization rates (61.6%) declined significantly (adjusted RR 2008/2009 vs. 2020-2021: 0.87, 95% CI: 0.79-0.95), with a more pronounced decrease in AF-specific readmissions (19.2%, adjusted RR: 0.24, 95% CI: 0.22-0.26). Younger patients (aged <70) showed a greater reduction in All-cause hospitalization rates and in AF-specific hospitalization rates compared to older age groups (RR 0.60, 95% CI: 0.55-0.66; RR 0.27, 95% CI: 0.23-0.30, respectively). CONCLUSIONS: While mortality rates following AF hospitalization remained unchanged, there was a significant reduction in hospitalizations, particularly AF-specific readmissions among younger patients. Targeted improvements in bleeding and cerebrovascular events were observed in specific subgroups, suggesting the potential benefit of tailored management strategies.

Auteurs: Yonatan Moshkovits, Tsahi T Lerman, Alon Barsheshet, Shir Tal, Gregory Golovchiner, Aharon Erez

---
Bron: International journal of cardiology, https://doi.org/10.1016/j.ijcard.2026.134952. Bijgewerkt 2026-10-28T01:47:51Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.